期刊文献+

肺癌相关基因SLC35F2RNA干扰重组慢病毒载体的构建和鉴定 被引量:1

Construction and identification of a recombinant lentiviral vector of RNA interference of lung cancer related gene SLC35F2
原文传递
导出
摘要 目的 针对肺癌相关基因SLC35F2构建RNA干扰(RNAi)重组慢病毒质粒并进行慢病毒包装,建立SLC35F2表达稳定抑制的H1299肺癌细胞株,并探讨SLC35F2基因的功能.方法 应用pGCSIL-PUR慢病毒载体构建针对SLC35F2的ShRNA载体,转染包装293T细胞,收集病毒上清转染肺癌细胞株H1299,经嘌呤霉素(puromycin)筛选并扩大培养得到稳定克隆;实时荧光定量聚合酶链反应(Real-time PCR)和Western blot检测癌细胞内SLC35F2的表达;CCK-8比色法检测细胞增殖;Annexin V-FITC/PI双染法检测细胞凋亡.结果 成功构建SLC35F2-ShRNA慢病毒载体(SLC-siRNA)及SLC35F2表达稳定抑制的肺癌细胞株,经过检测证实SLC-siRNA慢病毒载体对SLC35F2的抑制效率达81.8%;CCK-8检测显示SLC-siRNA稳定转染的H1299细胞株生长抑制率达16.3%,稳定转染株凋亡细胞百分比较阴性对照组明显升高(14.88%比3.16%,P<0.05).结论 慢病毒载体介导的靶向SLC35F2的RNAi可有效抑制SLC35F2表达,降低肺癌细胞的增殖能力,增加其凋亡比例. Objective To investigate the possibility of SLC35F2 inhibition by lentiviral vector-mediated RNA interference (RNAi) and the influence on cell proliferation and apoptosis in lung cancer cell line,and to set up a lung cancer cell line in which SLC35F2 is stably suppressed.Methods The lentiviral vector of siRNA targeted against SLC35F2 (SLC-siRNA) was constructed and transfected into the packaging cells 293T,and the viral supernatant was collected to transfect H1299 cells.After selection by puromycin and culture expansion,the stable cell clones were attained.Quantitative real-time fluorescent polymerase chain reaction (PCR) and Western blotting were used to detect the expression of SLC35F2.The effect of SLC35F2 silencing by RNAi on cell proliferation was quantified by CCK-8 assay.Annexin V-FITC/PI staining was employed to examine the apoptosis.Results Lentiviral vector SLC35F2-shRNA was constructed successfully.As compared with control group,the SLC35F2 expression was decreased to 81.8% in RNA and protein levels.CCK-8 revealed that the inhibition rate of H1299 cells transfected with SLC35F2 was 16.3%,and the apoptosis rate was significantly increased as compared with negative control group ( 14.88% vs 3.16% ,P 〈0.05 ).Conclusion Lentiviral vector-mediated RNA interference targeting against SLC35F2 can effectively inhibit SLC35F2 expression and cell proliferation.The lung cell line in which SLC35F2 gene was stably suppressed was successfully established.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第3期419-421,F0004,共4页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项且(30772486) 高等学校博士学科点专项科研基金资助项目(20070001713)
关键词 肺癌 RNAI 慢病毒载体 细胞增殖 Long carcinoma RNA interference Lentiviral vector Cell proliferation
  • 相关文献

参考文献8

  • 1Stankovic T,Byra PJ,Cooper PR,et al.Construction of a transcription map around the gene for ataxia telangiectasia:identification of at least four novel genes.Genomics,1997,40:265-276. 被引量:1
  • 2Bangsow T,Baumann E,Bangsow C,et al.The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier.J Cereb Blood Flow Metab,2008,28:1249-1260. 被引量:1
  • 3Nishimura M,Suzuki S,Satoh T,et al.Tissue-specific mRNA expression profiles of human solute carrier 35 transporters.Drug Metab Pharmacokinet,2009,24:91-99. 被引量:1
  • 4Shen CY,Zhao H.Molecular cloning,identification and analysis of lung squamous cell carcinoma-related genes.Lung Cancer,2002,67:235-241. 被引量:1
  • 5姜冠潮,卜梁,王俊,刘军.SLC35F2抗体制备与非小细胞肺癌组织中SLC35F2蛋白表达检测[J].中华实验外科杂志,2009,26(8):1046-1048. 被引量:2
  • 6卜梁,姜冠潮,杨帆,王云,刘军,王俊.SLC35F2在非小细胞肺癌中的表达及意义[J].中华实验外科杂志,2010(6):780-782. 被引量:1
  • 7Tominaga H,Ishiyama M,Ohseto F,et al.A water-soluble tetrazolium salt useful for colorimetric cell viability assay.Anal Commun,1999,36:47-50. 被引量:1
  • 8Kylarova D,Prochazkova J,Madarova J,et al.Comparison of the TUNEL,lamin B and annexin V methods for the detection of apoptosis by flow cytometry.Acta Histochemica,2002,104:367-370. 被引量:1

二级参考文献9

共引文献1

同被引文献11

  • 1Arigami T,Narita N,Mizuno R,et al. B7-h3 ligand expression by pri-mary breast cancer and associated with regional nodal metastasis. AnnSurg,2010,252:1044-1051. 被引量:1
  • 2Boorjian SA,Sheinin Y,Crispen PL,et al. T-cell coregulatory mole-cule expression in urothelial cell carcinoma:clinicopathologic correla-tions and association with survival. Clin Cancer Res,2008,14:4800-4808. 被引量:1
  • 3Yamato I,Sho M,Nomi T,et al. Clinical importance of B7-H3 expres-sion in human pancreatic cancer. Br J Cancer,2009,101:1709-1716. 被引量:1
  • 4Chapoval AI,Ni J,Lau JS,et al. B7-H3:a costimulatory molecule forT cell activation and IFN-gamma production. Natl Immunol,2001,2:269-274. 被引量:1
  • 5Suh WK,Gajewska BU,Okada H,et al. The B7 family memberB7-H3 preferentially down-regulates T helper type 1-mediated im-mune responses. Natl Immunol,2003,4:899-906. 被引量:1
  • 6Sun J,Chen LJ,Zhang GB,et al. Clinical significance and regulationof the costimulatory molecule B7-H3 in human colorectal carcinoma.CanceT Immunol Immunother,2010,59:1163-1171. 被引量:1
  • 7Yuan H,Wei X,Zhang G,et al. B7-H3 over expression in prostatecancer promotes tumor cell progression. J Urology,2011,186:1093-1099. 被引量:1
  • 8Hotz HG,Hines OJ,Masood R,et al. VEGF antisense therapy inhibitstumor growth and improves survival in experimental pancreatic canc-er. Surgery,2005,137:192-199. 被引量:1
  • 9赵文健,陈春燕,眭文妍,罗招阳.B7-H3及其与肿瘤关系的研究进展[J].医学综述,2009,15(22):3430-3433. 被引量:1
  • 10王晓通,钱倩,李雷,谢玉波,肖强.RNA干扰介导的转录因子E2F-1沉默对人胃癌裸鼠移植瘤生长的影响[J].中华实验外科杂志,2011,28(3):340-342. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部